TAUTOMERIC PHENOMENON OF FK506 IN SOLUTION

被引：0
|
作者：
NAMIKI, Y [1 ]
KIHARA, N [1 ]
FUJIOKA, M [1 ]
SHIMATANI, K [1 ]
FUJIWARA, A [1 ]
HANE, K [1 ]
YASUDA, T [1 ]
机构：
[1] FUJISAWA PHARMACEUT CO LTD,ANALYT RES LABS,OSAKA 532,JAPAN
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1992年 / 203卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：72 / ANYL
相关论文
共 50 条
  • [21] FK506 TREATMENT OF NONINFECTIOUS UVEITIS
    ISHIOKA, M
    OHNO, S
    NAKAMURA, S
    ISOBE, K
    WATANABE, N
    ISHIGATSUBO, Y
    TANAKA, S
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (06) : 723 - 729
  • [22] FK506 in the maturation of dendritic cells
    Cos, J
    Villalba, T
    Parra, R
    Gallardo, D
    Bilbao, I
    Margarit, C
    Massuet, L
    HAEMATOLOGICA, 2002, 87 (07) : 679 - 687
  • [23] CMV RETINITIS AND IMMUNOSUPPRESSION WITH FK506
    FRIBERG, TR
    PAUL, AA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 751 - 751
  • [24] CSA AND FK506 REGULATION OF CYTOKINES
    NGUYEN, D
    DEFORGE, L
    REMICK, D
    FASEB JOURNAL, 1991, 5 (06): : A1638 - A1638
  • [25] Interaction of FK506 with antizyme inhibitor
    Mangold, U
    Musicki, B
    Ohage, S
    Wendler, W
    Kirschbaum, B
    Leberer, E
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 242A - 242A
  • [26] FK506与心脏移植
    孟旭
    陈宝田
    中华胸心血管外科杂志, 1998, (02) : 58 - 60
  • [27] Behavioral assessment of neuroprotection by FK506
    Marston, HM
    Sharkey, J
    IMMUNOPHILINS IN THE BRAIN: FKBP LIGANDS: NOVEL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, 2000, : 173 - 182
  • [28] ORAL ABSORPTION OF FK506 IN RATS
    KAGAYAMA, A
    TANIMOTO, S
    FUJISAKI, J
    KAIBARA, A
    OHARA, K
    IWASAKI, K
    HIRANO, Y
    HATA, T
    PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1446 - 1450
  • [29] The mechanism of action of cyclosporin A and FK506
    Ho, S
    Clipstone, N
    Timmermann, L
    Northrop, J
    Graef, I
    Fiorentino, D
    Nourse, J
    Crabtree, GR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : S40 - S45
  • [30] Stability of FK506 in blood samples
    Alak, AM
    Lizak, P
    THERAPEUTIC DRUG MONITORING, 1996, 18 (02) : 209 - 211
12345